World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
33708
World Ranking
12113
National Ranking
6215

H. Ralph Schumacher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where H. Ralph Schumacher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 448 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

H. Ralph Schumacher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where H. Ralph Schumacher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1933 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

H. Ralph Schumacher is affiliated with the University of Pennsylvania in the United States. The scientist's work spans multiple areas in academic research, although specific details on fields of study, subfields, and main topics have not been documented in the available data.

There are no records of recent papers, frequent co-authors, or publication venues listed, which limits the ability to present a detailed account of their research output or collaborative networks. Similarly, information regarding book publications is not available.

Among the notable recognitions, H. Ralph Schumacher was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 1933. This fellowship is a designation that acknowledges contributions to the advancement of science.

This profile refrains from subjective interpretation and focuses solely on verifiable details concerning the scientist's affiliation and known distinctions.

Best Publications

  • Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    Daniel O. Clegg;Domenic J. Reda;Crystal L. Harris;Marguerite A. Klein

  • 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Dinesh Khanna;John D. FitzGerald;Puja P. Khanna;Sangmee Bae

  • Febuxostat compared with allopurinol in patients with hyperuricemia and gout

    Michael A. Becker;H. Ralph Schumacher;Robert L. Wortmann;Patricia A. MacDonald

  • 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

    Dinesh Khanna;Puja P. Khanna;John D. FitzGerald;Manjit K. Singh

  • Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

    H. Ralph Schumacher;H. Ralph Schumacher;Michael A. Becker;Robert L. Wortmann;Patricia A. MacDonald

  • Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

    Ted R Mikuls;J. T. Farrar;W. B. Bilker;S. Fernandes

  • The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

    Michael A Becker;H Ralph Schumacher;Luis R Espinoza;Alvin F Wells

  • Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?

    Joshua F. Baker;Eswar Krishnan;Lan Chen;H. Ralph Schumacher

  • Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

    Daniel O. Clegg;Domenic J. Reda;Edwin Mejias;Grant W. Cannon

  • Gout and the risk of acute myocardial infarction.

    Eswar Krishnan;Joshua F. Baker;Daniel E. Furst;H. Ralph Schumacher

  • Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

    Raphaela Goldbach-Mansky;Jennifer Lee;Angela McCoy;Joseph Hoxworth

  • Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome

    Eswar Krishnan;C. Kent Kwoh;H. Ralph Schumacher;Lewis Kuller

  • Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

    Naomi Schlesinger;Rieke E Alten;Thomas Bardin;H Ralph Schumacher

  • The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

    R Terkeltaub;J S Sundy;H R Schumacher;F Murphy

  • A LITERATURE REVIEW OF THE EPIDEMIOLOGY AND TREATMENT OF ACUTE GOUT

    Karissa Y. Kim;H. Ralph Schumacher;H. Ralph Schumacher;Elke Hunsche;Albert I. Wertheimer

  • Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

    H Ralph Schumacher;Judith A Boice;David I Daikh;Saurabh Mukhopadhyay

  • Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

    Michael A. Becker;H. Ralph Schumacher;Robert L. Wortmann;Patricia A. MacDonald

  • Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

    Michael A Becker;H Ralph Schumacher;Patricia A MacDonald;Eric Lloyd

  • Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

    H. R. Schumacher;M. A. Becker;E. Lloyd;P. A. MacDonald

  • Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of veterans affairs cooperative study

    Daniel O. Clegg;Domenic J. Reda;Michael H. Weisman;Warren D. Blackburn

Frequent Co-Authors

Tuhina Neogi
Tuhina Neogi Boston University
Jasvinder A. Singh
Jasvinder A. Singh Veterans Health Administration
Nicola Dalbeth
Nicola Dalbeth University of Auckland
Michael Becker
Michael Becker University of Chicago
Robert Terkeltaub
Robert Terkeltaub University of California, San Diego
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Hani El-Gabalawy
Hani El-Gabalawy University of Manitoba
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Hyon K. Choi
Hyon K. Choi Harvard Medical School
William V. Williams
William V. Williams GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options in healthcare extends beyond the traditional path of medical school. Many students consider flexible education alternatives such as the rn to bsn online programs, which allow registered nurses to advance their qualifications while continuing to work.

For those with a non-nursing background, direct entry msn programs for non nurses online provide a fast-track into advanced nursing roles without requiring a prior degree in nursing.

Prospective students seeking a straightforward entry into nursing may want to look at direct admit nursing programs, which simplify the application process and can offer clearer admission routes.

Alternatively, for those interested in the administrative side of healthcare, becoming a certified medical biller or coder is an excellent option. There are medical billing and coding schools that accept fafsa, making this pathway both accessible and affordable.

Each of these online pathways opens up new possibilities for a rewarding career in healthcare, providing flexibility, diverse opportunities, and accessible education options.

Best Scientists Citing H. Ralph Schumacher

Trending Scientists

Recently Published Articles